retatrutide clinical trials status VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide, an experimental weight-loss drug,
Description
Are Natural GLP-1 Boosters Right for You
Far along in research and development is Eli Lillys retatrutide, a triple agonist that adds glucagon to GLP-1 and GIP, and the requisite studies are underway.1,14 In addition, theres cagrisema from NovoNordisk, a blend of semaglutide (GLP-1 agonist) and a long-acting amylin (another pancreatic hormone) analog cargrilintide
The paraventricular nucleus integrates these signals and coordinates downstream responses including reduced food intake

Yousefi, M
And the evidence on its individual components is skimpy
